NCT03334760 is a clinical trial of Danish National Birth Cohort in Child Overweight, sponsored by University Hospital Bispebjerg and Frederiksberg.

Who is sponsoring NCT03334760?

NCT03334760 is sponsored by University Hospital Bispebjerg and Frederiksberg.

What drugs are being tested in NCT03334760?

Interventions in NCT03334760: Danish National Birth Cohort.

What condition does NCT03334760 study?

NCT03334760 studies Child Overweight.

Is NCT03334760 still recruiting?

NCT03334760 is currently completed. Last updated 8 November 2017.

Last reviewed 2017-11-08 · How we verify

NCT03334760

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Breastfeeding and Complementary Feeding in Relation to BMI and Overweight

Completed Last updated 8 November 2017

What this trial tests

trial testing Danish National Birth Cohort in Child Overweight in 100,418 participants. Completed in 1 November 2017.

Timeline

1 January 2017

Primary endpoint
1 November 2017

1 November 2017

Quick facts

Lead sponsor	University Hospital Bispebjerg and Frederiksberg
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100,418
Start date	1 January 2017
Primary completion	1 November 2017
Estimated completion	1 November 2017

Drugs / interventions tested

Danish National Birth Cohort

Conditions studied

Child Overweight — all drugs for Child Overweight →

Sponsor

University Hospital Bispebjerg and Frederiksberg

Who can join

Eligibility, female only, with Child Overweight. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study examines the associations between different types of infant feeding and BMI and overweight in childhood. The study is based on the Danish National Birth Cohort, established in 1996.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Breastfeeding and complementary feeding in relation to body mass index and overweight at ages 7 and 11 y: a path analysis within the Danish National Birth Cohort.
Morgen CS, Ängquist L, Baker JL, Andersen AN, et al · · 2018 · cited 20× · PMID 29566190 · DOI 10.1093/ajcn/nqx058

Verify or expand the search:

Other University Hospital Bispebjerg and Frederiksberg trials

Trials by the same sponsor.

NCT07060586 — The Effect of Sphenopalatine Ganglion Block on Headache and Vasalgia · NA · completed
NCT06911411 — PALLIATIVE ASSESSMENT COHORT IN THE GERIATRIC EMERGENCY SETTING · not yet recruiting
NCT06405750 — Left Atrial Appendage Arrhythmogenic and Thrombogenic Substrate · NA · recruiting
NCT06532825 — Cardiac Autonomic Dysfunction As a Sign of Irreversible Advanced Heart Failure · recruiting
NCT06184581 — Lithium Versus Lamotrigine in Bipolar Disorder, Type II · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03334760 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Bispebjerg and Frederiksberg
Last refreshed: 8 November 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03334760.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing